HRP20211354T1 - Tekuće kompozicije tiourilena - Google Patents
Tekuće kompozicije tiourilena Download PDFInfo
- Publication number
- HRP20211354T1 HRP20211354T1 HRP20211354TT HRP20211354T HRP20211354T1 HR P20211354 T1 HRP20211354 T1 HR P20211354T1 HR P20211354T T HRP20211354T T HR P20211354TT HR P20211354 T HRP20211354 T HR P20211354T HR P20211354 T1 HRP20211354 T1 HR P20211354T1
- Authority
- HR
- Croatia
- Prior art keywords
- composition
- use according
- vol
- combinations
- group
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 17
- 239000007788 liquid Substances 0.000 title claims 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 239000002562 thickening agent Substances 0.000 claims 3
- 239000000080 wetting agent Substances 0.000 claims 3
- 230000003139 buffering effect Effects 0.000 claims 2
- 239000003755 preservative agent Substances 0.000 claims 2
- 230000002335 preservative effect Effects 0.000 claims 2
- OOSZCNKVJAVHJI-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]piperazine Chemical compound C1=CC(F)=CC=C1CN1CCNCC1 OOSZCNKVJAVHJI-UHFFFAOYSA-N 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- 206010020850 Hyperthyroidism Diseases 0.000 claims 1
- 229940083916 aluminum distearate Drugs 0.000 claims 1
- RDIVANOKKPKCTO-UHFFFAOYSA-K aluminum;octadecanoate;hydroxide Chemical compound [OH-].[Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O RDIVANOKKPKCTO-UHFFFAOYSA-K 0.000 claims 1
- 229920001586 anionic polysaccharide Polymers 0.000 claims 1
- 150000004836 anionic polysaccharides Chemical class 0.000 claims 1
- 239000004359 castor oil Substances 0.000 claims 1
- 235000019438 castor oil Nutrition 0.000 claims 1
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 claims 1
- KDQPSPMLNJTZAL-UHFFFAOYSA-L disodium hydrogenphosphate dihydrate Chemical compound O.O.[Na+].[Na+].OP([O-])([O-])=O KDQPSPMLNJTZAL-UHFFFAOYSA-L 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims 1
- PMRYVIKBURPHAH-UHFFFAOYSA-N methimazole Chemical compound CN1C=CNC1=S PMRYVIKBURPHAH-UHFFFAOYSA-N 0.000 claims 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 1
- 229920000053 polysorbate 80 Polymers 0.000 claims 1
- 229940068968 polysorbate 80 Drugs 0.000 claims 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229940083037 simethicone Drugs 0.000 claims 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims 1
- 235000010234 sodium benzoate Nutrition 0.000 claims 1
- 239000004299 sodium benzoate Substances 0.000 claims 1
- 229940074545 sodium dihydrogen phosphate dihydrate Drugs 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 229960002178 thiamazole Drugs 0.000 claims 1
- 239000000230 xanthan gum Substances 0.000 claims 1
- 229920001285 xanthan gum Polymers 0.000 claims 1
- 235000010493 xanthan gum Nutrition 0.000 claims 1
- 229940082509 xanthan gum Drugs 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (13)
1. Oralna tekuća kompozicija koja sadrži:
i) 0.25% do 1% tež./vol. metimazola, njegove farmaceutski prihvatljive soli, njegovog solvata, ili njihovih kombinacija;
ii) najmanje 0.2% tež./vol. anionskog polisaharida, koji predstavlja gumu; i
iii) tekući nosač,
za uporabu u liječenju ili prevenciji hipertireoze kod mačaka.
2. Kompozicija za uporabu prema patentnom zahtjevu 1, koja sadrži najmanje oko 0.2% tež./vol. ksantan gume.
3. Kompozicija za uporabu prema bilo kojem od prethodnih patentnih zahtjeva, koja dodatno sadrži sredstvo za zgušnjavanje.
4. Kompozicija za uporabu prema patentnom zahtjevu 3, naznačena time što sredstvo za zgušnjavanje iznosi najmanje oko 0.5% tež./vol. ukupne zapremine kompozicije.
5. Kompozicija za uporabu prema patentnom zahtjevu 3 ili 4, naznačena time što je sredstvo za zgušnjavanje odabrano iz grupe koja se sastoji od aluminij distearata, glicerola, hidrogeniziranog ricinusovog ulja, polivinilpirolidona i njihovih kombinacija.
6. Kompozicija za uporabu prema bilo kojem od prethodnih patentnih zahtjeva, koja dodatno sadrži sredstvo za vlaženje.
7. Kompozicija za uporabu prema patentnom zahtjevu 6, naznačena time što sredstvo za vlaženje iznosi 0.1% do oko 1.0 % tež./vol. ukupne zapremine kompozicije.
8. Kompozicija za uporabu prema patentnom zahtjevu 6 ili 7, naznačena time što je sredstvo za vlaženje odabrano iz grupe koja se sastoji od polisorbata 80, simetikon emulzije i njihovih kombinacija.
9. Kompozicija za uporabu prema bilo kojem od prethodnih patentnih zahtjeva, koja dodatno sadrži otopinu za puferiranje pH.
10. Kompozicija za uporabu prema patentnom zahtjevu 9, naznačena time što je otopina za puferiranje pH odabrana iz skupine koja se sastoji od limunske kiseline, dinatrij fosfat dihidrata, natrij dihidrogen fosfat dihidrata i njihovih kombinacija.
11. Kompozicija za uporabu prema patentnom zahtjevu 9, naznačena time što je pH vrijednost kompozicije najmanje oko 4.3 ili veća.
12. Kompozicija za uporabu prema bilo kojem od prethodnih patentnih zahtjeva, koja dodatno sadrži konzervans.
13. Kompozicija za uporabu prema patentnom zahtjevu 12, naznačena time što konzervans sadrži natrij benzoat.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1411310.4A GB2527555B (en) | 2014-06-25 | 2014-06-25 | Stable methimazole liquid compositions |
| EP18197341.3A EP3441063B1 (en) | 2014-06-25 | 2015-06-23 | Thioureylene liquid compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP20211354T1 true HRP20211354T1 (hr) | 2021-11-26 |
| HRP20211354T8 HRP20211354T8 (hr) | 2022-03-04 |
Family
ID=51410113
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20220078TT HRP20220078T1 (hr) | 2014-06-25 | 2015-06-23 | Tekuće kompozicije tioureilena |
| HRP20211354TT HRP20211354T8 (hr) | 2014-06-25 | 2021-08-25 | Tekuće kompozicije tiourilena |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20220078TT HRP20220078T1 (hr) | 2014-06-25 | 2015-06-23 | Tekuće kompozicije tioureilena |
Country Status (18)
| Country | Link |
|---|---|
| US (5) | US10045967B2 (hr) |
| EP (2) | EP3441063B1 (hr) |
| JP (1) | JP6799465B2 (hr) |
| AU (1) | AU2015278962B2 (hr) |
| CA (1) | CA2952336C (hr) |
| CY (2) | CY1124535T1 (hr) |
| DK (2) | DK3160441T3 (hr) |
| ES (2) | ES2905083T3 (hr) |
| GB (1) | GB2527555B (hr) |
| HR (2) | HRP20220078T1 (hr) |
| HU (1) | HUE056787T2 (hr) |
| LT (2) | LT3160441T (hr) |
| NZ (1) | NZ728018A (hr) |
| PL (2) | PL3160441T3 (hr) |
| PT (2) | PT3160441T (hr) |
| RS (2) | RS62850B1 (hr) |
| SI (2) | SI3160441T1 (hr) |
| WO (1) | WO2015198033A1 (hr) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4096174A (en) * | 1977-07-01 | 1978-06-20 | American Cyanamid Company | Anionic naphthalene thioureido-diphenyloxides |
| DE3013839A1 (de) * | 1979-04-13 | 1980-10-30 | Freunt Ind Co Ltd | Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung |
| US5310742A (en) | 1992-11-30 | 1994-05-10 | Elias Alan N | Uses for thioureylenes |
| DE60139256D1 (de) * | 2000-05-03 | 2009-08-27 | Silva Joe D | Verfahren und vorrichtung zur herstellung von flüssigen verabreichungsformen |
| US20050158367A1 (en) * | 2004-01-16 | 2005-07-21 | The Procter & Gamble Company | Liquid compositions comprising one or more medicaments |
| US8993001B2 (en) * | 2006-01-26 | 2015-03-31 | Hill's Pet Nutrition, Inc. | Methods and compositions for treating feline hyperthyroidism |
| JP5319691B2 (ja) | 2007-11-15 | 2013-10-16 | ノバルティス アーゲー | プラジカンテル、マクロライドラクトン、シクロデキストリンおよび粘稠化剤を含む駆虫ペースト |
-
2014
- 2014-06-25 GB GB1411310.4A patent/GB2527555B/en active Active
-
2015
- 2015-06-23 PT PT157329087T patent/PT3160441T/pt unknown
- 2015-06-23 EP EP18197341.3A patent/EP3441063B1/en active Active
- 2015-06-23 PT PT181973413T patent/PT3441063T/pt unknown
- 2015-06-23 DK DK15732908.7T patent/DK3160441T3/da active
- 2015-06-23 SI SI201531780T patent/SI3160441T1/sl unknown
- 2015-06-23 PL PL15732908T patent/PL3160441T3/pl unknown
- 2015-06-23 LT LTEPPCT/GB2015/051824T patent/LT3160441T/lt unknown
- 2015-06-23 NZ NZ728018A patent/NZ728018A/en unknown
- 2015-06-23 CA CA2952336A patent/CA2952336C/en active Active
- 2015-06-23 HR HRP20220078TT patent/HRP20220078T1/hr unknown
- 2015-06-23 ES ES15732908T patent/ES2905083T3/es active Active
- 2015-06-23 ES ES18197341T patent/ES2884573T3/es active Active
- 2015-06-23 WO PCT/GB2015/051824 patent/WO2015198033A1/en active Application Filing
- 2015-06-23 RS RS20220049A patent/RS62850B1/sr unknown
- 2015-06-23 US US15/321,874 patent/US10045967B2/en active Active
- 2015-06-23 DK DK18197341.3T patent/DK3441063T3/da active
- 2015-06-23 JP JP2016575086A patent/JP6799465B2/ja active Active
- 2015-06-23 RS RS20211048A patent/RS62321B1/sr unknown
- 2015-06-23 SI SI201531684T patent/SI3441063T1/sl unknown
- 2015-06-23 EP EP15732908.7A patent/EP3160441B1/en active Active
- 2015-06-23 LT LTEP18197341.3T patent/LT3441063T/lt unknown
- 2015-06-23 HU HUE18197341A patent/HUE056787T2/hu unknown
- 2015-06-23 AU AU2015278962A patent/AU2015278962B2/en active Active
- 2015-06-23 PL PL18197341T patent/PL3441063T3/pl unknown
-
2018
- 2018-07-11 US US16/032,870 patent/US20180318262A1/en not_active Abandoned
-
2020
- 2020-04-24 US US16/857,348 patent/US11123327B2/en active Active
-
2021
- 2021-08-02 US US17/391,851 patent/US11738005B2/en active Active
- 2021-08-24 CY CY20211100755T patent/CY1124535T1/el unknown
- 2021-08-25 HR HRP20211354TT patent/HRP20211354T8/hr unknown
-
2022
- 2022-01-26 CY CY20221100062T patent/CY1124961T1/el unknown
-
2023
- 2023-07-11 US US18/350,152 patent/US20230404978A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20210085T1 (hr) | Pripravci i postupci za liječenje disfunkcije meibomske žlijezde | |
| MX2016000727A (es) | Composicion farmaceutica acuosa liquida que contiene derivados de ciclodextrina eterificada con conservante. | |
| PE20180038A1 (es) | Composiciones farmaceuticas topicas | |
| MX2022014313A (es) | Formulaciones para administracion oral de agentes activos con perfil de absorcion controlada. | |
| BR122021018243A8 (pt) | Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável | |
| MX365657B (es) | Composición novedosa y método de uso para controlar patógenos y prevenir enfermedades en semillas. | |
| BR112016022607B8 (pt) | Pó e método para aprimorar a aplicação tópica de minoxidil | |
| JP2014139241A5 (hr) | ||
| MX2015009552A (es) | Composiciones que incluyen agentes para conferir caracter hidrofobico y estabilizantes y metodos para elaborar y usar los mismos. | |
| RU2015141767A (ru) | Композиции и способы для местной доставки простагландинов в подкожный жир | |
| MX2017007178A (es) | Formulaciones liquidas estables de virus de vacuna. | |
| HRP20240314T1 (hr) | Farmaceutske gel kompozicije koje sadrže levodopu, karbidopu i entakapon | |
| BR112017016084A2 (pt) | composição e método para o tratamento da doença veno-oclusiva hepática | |
| EA201492091A1 (ru) | Фармацевтические композиции для местного применения, содержащие тербинафид и мочевину | |
| HRP20240166T1 (hr) | Postupak liječenja prader-willijevog sindroma | |
| AR083864A1 (es) | Producto para el cuidado oral y metodo para su uso y fabricacion | |
| RU2016129193A (ru) | Составы на основе берберина и их применение | |
| AR100001A1 (es) | Composiciones esporicidas clostridium difficile | |
| HRP20211354T1 (hr) | Tekuće kompozicije tiourilena | |
| HRP20201508T1 (hr) | Spojevi s antioksidativnim djelovanjem protiv slobodnih radikala i protupapalnom aktivnosti te odgovarajući farmaceutski pripravci za njegu kože | |
| RU2013110517A (ru) | Средство для профилактики или лечения неалкогольного стеатогепатита | |
| HRP20200504T1 (hr) | Lokalni preparati farmaceutskih i medicinskih proizvoda koji sadrže kombinacije sukralfata, hijaluronske kiseline, arginina i prirodnog hidratantnog sredstva | |
| AR089831A1 (es) | Una composicion y un metodo para tratar sustratos | |
| PE20150632A1 (es) | Composicion farmaceutica que tiene fluidez mejorada, agente medicional, y metodo para la produccion y uso del mismo | |
| JP2017519029A5 (hr) |